Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

See Locations Near You

Summary

The purpose of this study is to determine whether the combination of Ulocuplumab and Nivolumab is safe and effective in the treatment of pancreatic cancer and small cell lung cancer.

View Full Description

Full Description

Intervention model: Single group for Stage 1 DLT, then Parallel
Data Monitoring Committee: No (Stage 1) Yes (Stage 2 Randomized Ph2)

View Eligibility Criteria

Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

SCLC or PAC that is advanced or has spread to other parts of the body
Treated with at least one other chemotherapy that did not work or where cancer relapsed
Minimal limitations on activities of daily living as measured by Eastern Cooperative Oncology Group (ECOG) score of 0-1

Exclusion Criteria:

Patients with cancer that spread to the brain
Active, known or suspected autoimmune disease
Prior treatment with any drug that targets T cell co-stimulation pathways (such as checkpoint inhibitors)

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

61

Study ID:

NCT02472977

Recruitment Status:

Terminated

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

University Of Colorado Hosp
Aurora Colorado, 80045, United States
Indiana University Health
Indianapolis Indiana, 46202, United States
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
Baltimore Maryland, 21287, United States
Columbia University Medical Center (Cumc)
New York New York, 10032, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Huntsman Cancer Institute
Salt Lake City Utah, 84112, United States
Local Institution
Helsinki , 00029, Finland
Load More

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

61

Study ID:

NCT02472977

Recruitment Status:

Terminated

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider